News
bioMérieux, a world leader in the field of in vitro diagnostics, announces an agreement to acquire the assets of Day Zero Diagnostics, a US-based infectious disease diagnostics company using genome sequencing and machine learning to combat the rise of antibiotic-resistant infections.
Swipe to discover more
-
VETFIRE™: bioMérieux launches cutting-edge equine infectious respiratory disease testing
bioMérieux, a world leader in the field of in vitro diagnostics, today announced the launch of VETFIRE™, a ready-to-use PCR kit that makes testing for equine infectious respiratory diseases easier and faster. -
Impact of Antimicrobial Stewardship Programs on Patient Care in the ICU
Following their introduction over half a century ago, Intensive Care Units (ICUs) have played an invaluable role in caring for patients who are critically ill or seriously injured. However, infections such as healthcare-associated infections (HAIs) are a common problem in the ICU, resulting in the frequent use and sometimes overuse of life-saving antibiotics in those settings. While antimicrobial resistance (AMR) is a process that naturally occurs over time, it is important to note that the overuse and misuse of antibiotics, even when utilized in intensive care environments, is contributing to the further emergence of resistant pathogens. -
bioMérieux Embarks its Customers in a Circular Economy Initiative
BIOLOOP™ is an innovative project to recycle plastic Petri dishes from infectious waste into new reagents packaging—reducing CO₂ emissions and supporting a circular economy in healthcare.
Enabling Decision-Making
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19